On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of ...

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Report and free match highlights from the Carabao Cup third-round tie between Coventry and Tottenham at the Coventry Building Society Arena on Wednesday night; Late goals from Djed Spence and ...

Plumes of smoke filled the air around a road in Coventry due to a 'significant fire'. Crews from Foleshill and Coventry fire stations raced to the scene in Sydnall Road last night (September 23).

London: Neurocrine Biosciences said on Thursday it will halt the development of its experimental drug, aimed at improving cognitive function in patients with schizophrenia, after it did not ...

Mark Robins admits Coventry City have suffered a “massive blow” with the news that key midfield man Ben Sheaf has aggravated the ankle injury that kept him out for most of the pre-season.

Officers later found stolen cars, fake documents and drugs. Police said a man was held on Coventry Road after officers spotted a stolen vehicle. It prompted a search at a property where another stolen ...

When a rash broke out on the hand of a patient taking part in the trial of a promising schizophrenia drug, clinical investigator Greg Mattingly began to fret that it might be an allergic reaction.

Neurocrine said it will focus its resources on late-stage development of its other schizophrenia and depression drug candidates. Shares of the company were down 2.5% in extended trading.